Diane J. Burgess
Distinguished Professor/Pharmaceutical Science

Are you Diane J. Burgess?

How to update your information.
Grants

133 Grants

Prevention of Amputations Using Magnetic Growth Factors
Sponsor: Cleveland Clinic Foundation
Authors: Diane J Burgess
2004-09-01 - 2009-08-31
Development of In-Vitro Testing Methods for Nano-Suspensions
Sponsor: United States Pharmacopeial Convention
Authors: Diane J Burgess
2006-06-01 - 2007-05-31
Miniaturized, Wireless-Integrated and Implantable Glucose Sensors
Sponsor: DHHS/NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Authors: Diane J Burgess
2003-04-01 - 2008-03-31
Nanotube-Based Two-Stage Vector for Gene Delivery
Sponsor: DHHS/NIH/National Institute of Biomedical Imaging and Bioengineering
Authors: Diane J Burgess
2008-12-01 - 2010-11-30
Prevention of Amputations Using Magnetic Growth Factors
Sponsor: DHHS/NIH/National Institutes of Health/Cleveland Clinic Foundation
Authors: Diane J Burgess
2003-07-01 - 2008-06-30
Delineation of long-acting parenteral products through correlation of physical properties with in vitro and in vivo release kinetics by multiphysics simulation and PK modeling
Sponsor: DHHS/FDA/Food and Drug Administration/University of Maryland, Baltimore
Authors: Diane J Burgess
2021-06-01 - 2021-11-30
Method of Dissolution for Nanosuspensions/Nanoparticles
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Diane J Burgess
Funding: $199,978
2011-08-19 - 2013-12-31
Impact of Polymer Attributes on the Performance of In Situ Forming Implants
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Diane J Burgess
Funding: $973,184
2020-03-10 - 2023-09-09
2006-2007 Fellowship: Development of In Vitro Testing Methods for Parenteral Liposome Products-Upkar Bhardwaj
Sponsor: United States Pharmacopeial Convention
Authors: Diane J Burgess
Funding: $192,000
2007-08-15 - 2010-08-31
Computational Drug Delivery: Leveraging Predictive Models to Develop Bioequivalent Generic Long-Acting Injections
Sponsor: DHHS/FDA/Food and Drug Administration/Qrono
Authors: Diane J Burgess
Funding: $137,194
2018-07-01 - 2019-10-31
Microport: An Intaperitoneal Artificial Pancreas Minimally Invasive Catheter Replacement Port
Sponsor: DHHS/NIH/National Institutes of Health/PhysioLogic Devices
Authors: Diane J Burgess
2019-09-01 - 2021-08-31
Continuous Processing and Characterization of Novel Liposomes
Sponsor: FujiFilm USA
Authors: Diane J Burgess
2019-06-01 - 2019-08-01
Continuous Manufacturing and Characterization of Complex Parenteral Formulations
Sponsor: American Foundation for Pharmaceutical Education
Authors: Diane J Burgess
2020-09-01 - 2021-08-31
Development of Real-Time and Accelerated Dissolution Methods for a Long-Acting Levonorgestrel Intrauterine System
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Diane J Burgess
Funding: $1,755,000
2015-09-15 - 2025-08-31
Subcutaneously Injectable Implant for Extended Release Naproxen
Sponsor: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation
Authors: Diane J Burgess
2021-01-01 - 2022-12-31
Formulation of Oral Thin Films for Rapid Dissolution and Absorption Sublingually
Sponsor: American Foundation for Pharmaceutical Education
Authors: Diane J Burgess
2021-06-01 - 2022-08-31
A continuous manufacturing system for nucleic acid lipid nanoparticles to address the demand of future therapeutics and vaccines
Sponsor: NSF/ENG/Directorate for Engineering/DIANT Pharma
Authors: Diane J Burgess
Funding: $46,500
2022-02-15 - 2023-03-31
Evaluation and Development of Dissolution Testing Methods for Semisolid Ocular Drug Products
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Diane J Burgess
Funding: $437,349
2014-09-15 - 2017-08-31
Development of In Vitro Release Testing Methods for PLGA/PLA Microspheres Using USP Apparatus 4
Sponsor: Flexion Therapeutics
Authors: Diane J Burgess
Funding: $387,848
2013-04-24 - 2018-08-15
Microsphere based Long-acting therapy for overcoming smoking addiction
Sponsor: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation
Authors: Diane J Burgess
2024-01-01 - 2025-12-31